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Abstract
In 2014, China experienced the worst outbreak of dengue fever in the last decade with over 40,000 
dengue cases including six deaths by the end of October. As one of the “neglected” tropical 
diseases, dengue is affecting substantially increasing number of people and proportion of global 
population due to factors including globalization, human settlement, and possibly climate change. 
Here, the authors summarized the most recent data about dengue outbreaks in China and reviewed 
the global trend of dengue epidemiology. Future directions for dengue surveillance, control and 
prevention are also introduced.
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In 2014, China experienced the worst outbreak of dengue fever (DF) in the last decade (Fig. 
1a, b). A total of 44,591 dengue cases were reported to the national notifiable infectious 
diseases reporting system by the end of October including six deaths, and 99 % of cases 
were reported in south China provinces, such as Guangdong, Fujian, Yunnan and Zhuang 
Autonomous Region [1]. On November 3, the U.S. Centers for Disease Control and 
Prevention (CDC) issued a travel notice for Guangdong province, China because of the 
dengue outbreak [2].
1 The global threat of dengue
Dengue fever (DF), caused by any one of the four closely related dengue viruses (DENV 1–
4), is a viral illness transmitted by Aedes mosquitoes. Originating in monkeys, dengue 
viruses were transmitted to humans between 100–800 years ago, and dengue remained a 
relatively minor and geographically restricted disease until the 1950s when epidemics 
occurred in the Philippines and Thailand [3, 4]. Dengue has emerged as a worldwide 
problem, with a 30-fold increase in incidence globally in the past 50 years (Fig. 2) [4]. 
Today, dengue is regarded as the most prevalent and rapidly spreading mosquito-borne viral 
disease of humans [4]. It is found in at least 100 tropical and subtropical countries, including 
Correspondence to: Yuan Li, liy@cn.cdc.gov.
Conflict of interest: The authors declare that they have no conflict of interest. The findings and conclusions of this report are those of 
the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.
HHS Public Access
Author manuscript
Sci Bull Sci Found Philipp. Author manuscript; available in PMC 2016 April 01.
Published in final edited form as:
Sci Bull Sci Found Philipp. 2015 April ; 60(7): 661–664. doi:10.1007/s11434-015-0756-5.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
countries in Africa, Southeast Asia, the western Pacific, the Americas, the Caribbean, and 
the eastern Mediterranean regions [3, 5]. More than one- third of the world’s population 
lives in areas at risk of infection with dengue virus [3], and a recent estimate using 
cartographic approaches in 2013 showed that 390 million people have dengue virus 
infections per year, of which 96 million cases manifest symptoms worldwide [6].
Dengue is a complex disease with a wide spectrum of clinical presentation. Classic DF is 
characterized by acute onset of high fever 3–14 days after the bite of an infected mosquito, 
and the high fever can persist for 2–7 days accompanied by frontal headache, retro-orbital 
pain, myalgias, arthralgias, rash, and low white blood cell count [7, 8]. Due to the severe 
muscle, joint and bone pains, dengue is also known as “break bone fever”. Most dengue 
patients recover after a few days, but some DF patients develop dengue hemorrhagic fever 
(DHF) or dengue shock syndrome (DSS), which are severe and sometimes fatal forms of the 
disease [7]. About three quarters of dengue infections can be asymptomatic, especially in 
children and those with previous dengue infection, but they can still infect mosquitoes [3, 7]. 
However, secondary dengue infection is one of the two factors thought to be associated with 
increased risk of disease severity; the other factor is infection by particularly virulent strains 
of dengue viruses [8].
At present, no vaccine exists to prevent dengue infection, nor are there specific medications 
to treat the disease. The most effective protective measures are those that prevent mosquito 
bites, namely vector control [3]. The main arthropod vector for dengue virus transmission is 
Aedes aegypti, and a second, less effective vector is Aedes albopictus [8]. Control of dengue 
vectors has mainly been addressed by community-based source reduction: The elimination 
of containers that are favorable sites for oviposition and development of the aquatic stages 
[4]. For individuals, preventive measures include sleeping under a mosquito bed net, 
eliminating mosquito indoors and wearing repellent [3].
The World Health Organization (WHO) described dengue as a “neglected” tropical disease 
(NTD) in its Dengue Prevention and Control Strategy 2012–2020, due to the lack of global 
coordination efforts, research, and political will [4]. The contemporary worldwide 
distribution of the risk of dengue virus infection and its public health burden is poorly 
known, and the greatest uncertainties in national burden estimates are in India, Indonesia, 
Brazil, and China [6]. The economic burden of dengue on both governments and individuals 
is high. Based on a systematic review analysis, the estimated cost of dengue disease in the 
Americas including North America, Central America and Mexico, the Andean region, 
Brazil, the Southern cone, and the Caribbean region is 2.1 billion USD per year on average, 
excluding cost on vector control [9]. Another 12-country economic analysis also showed 
high dengue burden in Southeast Asia, with an annual average of 950 million USD resulted 
from 2.9 million dengue episodes and 5,906 deaths [10]. Information on economic burden of 
dengue in China, however, is not available.
2 Dengue in China
NTDs including dengue are still widespread and create a substantial burden in China [11]. 
Infectious diseases in China are divided into three categories (A, B, and C) according to 
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their transmission modes, speed, and hazard to humans; DF, together with Severe Acute 
Respiratory Syndrome (SARS), H1N1 influenza, rabies, tuberculosis etc., belong to 
infectious diseases category B. In 2005, China established a national monitoring program for 
DF in humans and vector monitoring in Aedes mosquitoes, focusing on five provinces 
(Guangdong, Fujian, Yunnan, Guangxi Autonomous Region, and Hainan) with 16 national 
monitoring sites. Other efforts that China has made to prevent and control dengue include 
control of mosquito vector density, enhanced surveillance for imported cases, improvement 
of diagnosis and treatment, enhancing the cooperation among the related different public 
health departments and neighboring countries, and engaging communities to combat the 
epidemic [11, 12]. In response to the dengue outbreak in 2014, four technical guidelines 
[13], including surveillance of DF cases, laboratory tests and diagnosis, surveillance of 
dengue vectors, and control of dengue vectors, were developed and issued by China CDC, 
together with the previous two dengue guidelines (Diagnosis and Treatment of Dengue 
Fever in 2014 and Dengue Outbreak Investigation and Management in 2006) issued by the 
National Commission for Health and Family Planning, formed a complete national technical 
framework for dengue control and prevention [13].
DF in China’s mainland was characterized as an imported epidemic disease and was not 
confirmed as an endemic in the past [4], but after the 2014 large dengue outbreak, it is 
possible that DENV will be endemic in southern China, especially in Guangdong [14]. All 
four dengue viruses are detected in China [11]. Upon review of the surveillance data 
collected by the monitoring program started in 2005 with a focus on southern provinces as-
described above for the past years, a changing circulation pattern of DF has been observed 
in Guangdong, from non-endemicity (no virus sustained), to hypo-endemicity (one serotype 
present), and even hyper-endemicity (multiple serotypes present) of dengue infections [15]. 
In the last two decades, the biological behavior and vectorial capacity of Aedes mosquitoes 
have changed significantly in China, possibly due to urbanization and global climate 
changes [12]. Therefore, dengue illnesses have spread from southern coastal regions to the 
relatively northern and western areas of the country, and the interval between epidemics has 
become shorter since the 1990s compared to those that occurred before the 1990s, beginning 
with the first reported outbreak of DF in Guangdong in 1978 [11, 12]. In 2013, a severe 
dengue outbreak of 1,245 cases happened in Yunnan Province, with a significant proportion 
of severe dengue cases; DENV-3 was identified to be the cause of the out- break using real-
time RT-PCR assays [16]. In the same year, the first dengue outbreak in central China was 
reported in Henan Province, a northern temperate province of China; 73 of 106 suspected 
DF cases of this outbreak were confirmed DENV-3 infections [17].
The recent data from Guangdong, the most affected province of the 2014 dengue outbreak, 
showed that as of December 15, 20 prefectures reported a total of 45,171 clinical or 
laboratory confirmed dengue cases according to the case definition in China’s dengue 
surveillance guideline 2005, with the highest number (37,354) reported in the capital city of 
Guangzhou, followed by Foshan City with 3,542 cases [18]. According to the Guangdong 
Provincial CDC, the peak of the dengue outbreak was reached on October 1, and case 
numbers started to decline after October 11 [19]. Guangdong is located in a subtropical zone 
in China, and it has a high relative humidity, which may have created climatic and 
Li and Wu Page 3
Sci Bull Sci Found Philipp. Author manuscript; available in PMC 2016 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
environmental conditions conducive to the proliferation of Aedes species. The DF epidemic 
area in Guangdong was mainly located in the old town which is under construction, and the 
poor sanitary infrastructure may contribute to this DF epidemic. A previous study from 
Guangdong showed that urbanization substantially increased the density, larval development 
rate, and adult survival time of Aedes species, which in turn potentially increases the vector 
capacity, and therefore, disease transmissibility [20].
3 Future directions for dengue control
Experts predict geographic expansion and increased incidence of dengue in the future [8]. 
The expansion of dengue is multifactorial, and the main “drivers” of increase in dengue 
incidence include globalization, travel, trade, socioeconomic factors, human settlement, viral 
evolution, and possibly also climate change [8].
With the substantial increase in the number of people and the proportion of the global 
population at risk of DF, a safe and effective dengue vaccine is greatly needed. Very 
recently, a tetravalent dengue vaccine has been reported showing efficacy against DF and 
severe DF, leading to fewer hospitalizations in a randomized, blinded, placebo- controlled 
trial in Latin America [21]. The observed reduction in the severity of clinical disease and the 
prevention of hospitalization are encouraging, and the progress is considered a milestone in 
dengue prevention and control [22].
Accurate disease burden estimates and sensitive out- break monitoring for dengue through 
improved epidemiological and entomological surveillance are another key for dengue 
control. Dengue is an acute febrile illness, and only diagnostic testing can accurately 
determine the etiology of the syndrome and differentiate dengue from acute febrile illness 
caused by other pathogens. However, the current dengue surveillance programs in China and 
internationally are all syndrome based (that is, entail clinical case-definitions without 
laboratory confirmation) and almost all are passive [23]. With the development of sensitive 
and specific diagnostic algorithms and increased awareness of dengue expansion, robust, 
laboratory-based dengue surveillance is needed to document and monitor the regional and 
global dengue incidence, and to evaluate the effectiveness of dengue control interventions. 
More accurate epidemiological and surveillance data will support greater political 
prioritization for this currently “neglected” disease. It would also allow improved decision 
making and rational allocation of financial, research, and other resources to the areas of 
greatest need [24].
Although the current control approach has shown some effectiveness, innovative vector 
control tools are still needed to control mosquito more effectively [25]. Recent systematic 
review and meta-analysis showed low relative effectiveness (25 %) with high heterogeneity 
of community-based interventions with educational message for dengue control [26]. 
Vector-borne diseases such as dengue have raised public health concern worldwide due to 
climate change, global trade, worldwide travel, and urban crowding. “One Health” is a 
relatively new term, but the concept that the health of humans is connected to the health of 
animals and the environment has long been recognized [27]. It has become more important 
in recent years because many factors have changed the interactions among humans, animals, 
Li and Wu Page 4
Sci Bull Sci Found Philipp. Author manuscript; available in PMC 2016 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
and the environment, which have caused the emergence and reemergence of many diseases, 
including dengue. Successful public health interventions for disease control require the 
cooperation of the human health, veterinary health, and environmental health communities 
[27].
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Fig. 1. 
Number of reported dengue fever (DF) cases in China’s mainland from 2004 to 2013 (a) and 
from January to October 2014 (b). Data source: Notifiable infectious disease reporting 
summary, China CDC [1]
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Fig. 2. 
Average number of dengue and severe dengue (DHF) cases reported to WHO from 1955 to 
2007 [4]
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